Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Estramustine in Metastatic Prostate Cancer
NCT00002775Phase 2Unknown
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Feb 1998
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, estramustine in prostate cancer (PCa), sponsored by Herbert Irving Comprehensive Cancer Center. Status: unknown.
02
Drugs
docetaxelestramustine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00002775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002775.